Clinical Report: Tracing Metabolic Inflexibility in Fanconi Anemia

Overview

This study investigates metabolic inflexibility in patients with Fanconi anemia (FA) using a stable-isotope glucose tracer challenge. The findings reveal significant challenges in nutrient processing and energy metabolism, highlighting the need for tailored clinical management strategies.

Background

Fanconi anemia is primarily recognized as a genetic disorder affecting DNA repair, leading to severe hematologic issues and increased cancer risk. However, patients often experience metabolic challenges, including difficulties in weight gain and energy maintenance. Understanding these metabolic issues is crucial for improving patient quality of life and guiding clinical interventions.

Data Highlights

The study employed a stable-isotope glucose tracer to assess metabolic pathways in real time, revealing insights into nutrient handling and energy expenditure in FA patients.

Key Findings

• Stable-isotope glucose tracing allowed for real-time tracking of metabolic pathways in FA patients.
• FA patients exhibited significant metabolic inflexibility, impacting their ability to process nutrients effectively.
• Indirect calorimetry measurements indicated altered energy expenditure patterns in the cohort.
• Hormonal profiling revealed disruptions in endocrine signals related to metabolism.
• Findings suggest a need for comprehensive metabolic assessments in FA management.

Clinical Implications

Healthcare providers should incorporate metabolic assessments into the routine care of patients with Fanconi anemia, focusing on energy expenditure and nutrient processing. Collaboration with endocrinology and nutrition specialists is essential to address the metabolic challenges faced by these patients.

Conclusion

The study underscores the importance of understanding metabolic inflexibility in Fanconi anemia, which has significant implications for patient management and quality of life. Further research is needed to develop targeted interventions.

References

1. Blood Cancer Journal, 2015 -- Fanconi anemia gene variants in therapy-related myeloid neoplasms
2. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Kidney Hyperfiltration and Mitochondrial Changes Are Associated With eGFR Decline in Young People With Type 1 Diabetes
3. Dana-Farber, 2023 -- Researcher Gains Insight into Rare Genetic Diseases
4. Fanconi Anemia Clinical Care Guidelines_5th Edition 2020_web
5. Bone Marrow Transplantation, 2025 -- Indications for haematopoietic cell transplantation and CAR-T for haematological diseases
6. PubMed, 2023 -- Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation
7. The Journal of Clinical Endocrinology & Metabolism — Metabolic Bone Disease Linked to Cystinosis in Patients of Varying Ages and CKD Stages 1 to 5D/T
8. Fanconi Anemia Clinical Care Guidelines_5th Edition 2020_web
9. Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations | Bone Marrow Transplantation
10. Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility - PubMed